Johnson & Johnson’s McNeil Consumer & Specialty Pharmaceuticals launched a $30 million campaign for chewable Tylenol, targeting a younger-than-usual audience: 30- and 40-somethings with kids. The TV, print and poster ads, created by Deutsch, aim to capture the 30% of households where families fail to take headache remedies for reasons of inconvenience, according to Advertising Age.
From the September 01, 2006 Issue of MM+M - Medical Marketing and Media
